New drug trial targets rare blood disorder that destroys red cells
NCT ID NCT07212426
Summary
This study is testing an investigational injection called LP-005 in adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disease where the immune system attacks and destroys red blood cells. Researchers will measure if the treatment reduces blood cell destruction, improves anemia, and reduces the need for blood transfusions. The trial will also monitor side effects and how the drug behaves in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNH - PAROXYSMAL NOCTURNAL HEMOGLOBINURIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Nanjing Medical University
Nanjing, China
Conditions
Explore the condition pages connected to this study.